Q1 Late onset intrauterine growth retardation (IUGR) is associated with symmetric growth retardation .

True      False      Don't Know


Q2 The glycogen and fat content in symmetric IUGR is relatively normal .

True      False      Don't Know


Q3 Asymmetric growth retardation is associated with an increased risk for asphyxia.

True      False      Don't Know


Q4 Management of IUGR should start once an infant is delivered.

True      False      Don't Know


Q5 Causes of IUGR include maternal diabetes.

True      False      Don't Know


Q6 Pre-eclampsia may be associated with a higher incidence of large-for-gestational-age (LGA) babies compared to normotensive mothers.

True      False      Don't Know


Q7

Pre-eclampsia is associated with a higher incidence of small-for-gestational-age babies.

True      False      Don't Know


Q8 Infants of diabetic mothers have a higher risk of neonatal mortality due to hypoglycaemia.

True      False      Don't Know


Q9 An infant is born with a birth-weight of 4.9 kg. Modified oral glucose tolerance test done at 35 weeks' gestation was normal. This baby is at an increased risk of hypoglycaemia.

True      False      Don't Know


Q10

Foetus of a severely pre-eclamptic or eclamptic patient usually has few problems with respiratory distress syndrome.

True      False      Don't Know


Q11

Methlydopa used in the treatment of maternal hypertension is associated with a higher risk of fetal malformations.

True      False      Don't Know


Q12

Babies who are small at birth or during infancy have a higher risk of non-insulin dependent diabetes mellitus, hypertension and heart disease as adults.

True      False      Don't Know

 


 

 

 

 

 

 

 

 

 

 

 

 

Your Score is  point(s) !

 


Marking Scheme

Correct answer - Add 1 point
Wrong answer - Minus 1 point
DK/no answer - 0 point

 

 

Answers

Q1 Late onset intrauterine growth retardation (IUGR) is associated with symmetric growth retardation .

Ans : False.
Comment : Late onset IUGR is associated with asymmetric growth retardation


Q2 The glycogen and fat content in symmetric IUGR is relatively normal .

Ans : True
Comment : Hence risk for hypoglycaemia is low


Q3 Asymmetric growth retardation is associated with an increased risk for asphyxia.

Ans : True.


Q4 Management of IUGR should start once an infant is delivered.

Ans : False
Comment : Appropriate maternal-fetal care is necessary in the antenatal period


Q5 Causes of IUGR include maternal diabetes.

Ans : True.
Comment : This occurs especially when diabetes is of early onset, poorly controlled and if associated with congenital anomalies


Q6 Pre-eclampsia may be associated with a higher incidence of large-for-gestational-age (LGA) babies compared to normotensive mothers.

Ans : True
Comment : A rate of 4.7% vs 2.2% (p<0.05)reported. Am J Obstet & Gynecol 2000; 183:148-155


Q7

Pre-eclampsia is associated with a higher incidence of small-for-gestational-age babies.

Ans : True
Comment: Odds ratio of 2.56 (CI:1.92-3.41) reported. Am J Obstet & Gynecol 2000; 183:148-155


Q8 Infants of diabetic mothers have a higher risk of neonatal mortality due to hypoglycaemia.

Ans : False
Comment: Mortality of IDM is quite low presently and is usually due to congenital anomalies


Q9 An infant is born with a birth-weight of 4.9 kg. Modified oral glucose tolerance test done at 35 weeks' gestation was normal. This baby is at an increased risk of hypoglycaemia.

Ans : True.
Comment: All LGA babies need to be monitored for hypoglycaemia


Q10

Foetus of a severely pre-eclamptic or eclamptic patient usually has few problems with respiratory distress syndrome.

Ans : True


Q11

Methlydopa used in the treatment of maternal hypertension is associated with a higher risk of fetal malformations.

Ans : False
Comment: There's no increase foetal malformations with methlydopa, beta-blockers and clonidine


Q12

Babies who are small at birth or during infancy have a higher risk of non-insulin dependent diabetes mellitus, hypertension and heart disease as adults.

Ans : True
Comment: Association first reported by Barker et al in Lancet 1993; 341: 938-941

 


[ Back ]